Follow
José Luis Calleja
José Luis Calleja
Hospital Universitario Puerta de Hierro Majadahonda
Verified email at uam.es - Homepage
Title
Cited by
Cited by
Year
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
M Reig, Z Mariño, C Perelló, M Iñarrairaegui, A Ribeiro, S Lens, A Díaz, ...
Journal of hepatology 65 (4), 719-726, 2016
10232016
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
5562014
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement
A Albillos, A de la Hera, M González, JL Moya, JL Calleja, J Monserrat, ...
Hepatology 37 (1), 208-217, 2003
5532003
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 …
M Manns, D Samuel, EJ Gane, D Mutimer, G McCaughan, M Buti, ...
The Lancet Infectious Diseases 16 (6), 685-697, 2016
5092016
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled …
C Villanueva, A Albillos, J Genescà, JC Garcia-Pagan, JL Calleja, ...
The lancet 393 (10181), 1597-1608, 2019
4662019
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ...
Journal of hepatology 64 (4), 800-806, 2016
4362016
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
4072014
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients
H Hinrichsen, Y Benhamou, H Wedemeyer, M Reiser, RE Sentjens, ...
Gastroenterology 127 (5), 1347-1355, 2004
4072004
Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis
JG Abraldes, C Villanueva, C Aracil, J Turnes, M Hernandez-Guerra, ...
Gastroenterology 150 (5), 1160-1170. e3, 2016
3152016
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ...
Hepatology 66 (5), 1444-1453, 2017
3042017
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ...
The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017
3032017
Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study
A Berzigotti, A Albillos, C Villanueva, J Genescá, A Ardevol, S Augustín, ...
Hepatology 65 (4), 1293-1305, 2017
2822017
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
2712014
Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis
S Lens, E Alvarado-Tapias, Z Mariño, MC Londoño, E LLop, J Martinez, ...
Gastroenterology 153 (5), 1273-1283. e1, 2017
2502017
Portal hypertension–related complications after acute portal vein thrombosis: impact of early anticoagulation
J Turnes, JC García–Pagán, M González, C Aracil, JL Calleja, C Ripoll, ...
Clinical Gastroenterology and Hepatology 6 (12), 1412-1417, 2008
2402008
Propranolol Plus Placebo Versus Propranolol Plus Isosorbide–5–Mononitrate in the Prevention of A First Variceal Bleed: A Double–Blind Rct
JC García-Pagán, R Morillas, R Bañares, A Albillos, C Villanueva, C Vila, ...
Hepatology 37 (6), 1260-1266, 2003
2132003
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ...
Journal of Hepatology 73 (6), 1368-1378, 2020
2012020
Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis
M Simón-Talero, D Roccarina, J Martínez, K Lampichler, A Baiges, G Low, ...
Gastroenterology 154 (6), 1694-1705. e4, 2018
2012018
Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension
C Villanueva, A Albillos, J Genesca, JG Abraldes, JL Calleja, C Aracil, ...
Hepatology 63 (1), 197-206, 2016
1972016
Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution
M Reig, Z Mariño, C Perelló, M Iñarrairaegui, A Ribeiro, S Lens, A Díaz, ...
J Hepatol 65 (4), 719-26, 2016
1932016
The system can't perform the operation now. Try again later.
Articles 1–20